Persistent or Debilitating Fatigue If your tiredness isn't improving after the first few weeks on a new dose, or if it's so severe that it prevents you from performing your daily activities such as working, caring for family, or managing your household, it's time to seek medical advice
Peptide therapy should not be treated as a set-it-and-forget-it approach
A good surgeon should listen, listen, and listen
Moreover, the percentage of participants in clinical trials who stopped the treatment due to AE was 515% with most of the new agents, and this percentage was up to 2030% with some of GLP-1/glucagon RA in phase 2 trials so a considerable proportion of people may not be able to tolerate the new obesity pharmacotherapies or may be unable to titrate them to the higher and most effective doses
If the inflammation is coming from an autoimmune condition, active infection, untreated sleep apnea, heavy alcohol use, or another non-metabolic cause, the effect may be modest or incomplete